ABSTRACT OF THE PRESENTATION
Antibiotics are losing effectiveness worldwide as a consequence of selection pressure imposed by the massive use of
antibiotics and rapid spread of resistant pathogens. The hidden epidemic of antibiotic resistance kills more people than
HIV/AIDS or malaria but has received far less attention than other diseases. This talk covers the current state of the
world’s antibiotics, drivers of resistance, and feasible interventions to combat antibiotic resistance. See: R. Laximinarayan.
2022. The overlooked pandemic of antimicrobial resistance. The Lancet, https://doi.org/10.1016/S0140-6736(22)00087-3.
SPEAKER: RAMANAN LAXIMINARAYAN
BIOGRAPHY: Laxminarayan is founder and director of the Center for Disease Dynamics, Economics & Policy (CDDEP)
in Washington, D.C. and New Delhi, and a senior research scholar at Princeton University. He is an affiliate professor at
the University of Washington and a visiting professor at the University of Strathclyde in Scotland. Laxminarayan chairs
the board of GARD-P, a global product development partnership created by the World Health Organization, that aims
to develop and deliver new treatments for bacterial infections. He is the founder and board chair at HealthCubed, which
works to improve access to healthcare and diagnostics worldwide.
Since 1995, Laxminarayan has worked to improve the understanding of antibiotic resistance as a problem of managing a
shared global resource. His work encompasses extensive peer-reviewed research, public outreach, and direct
engagement across Asia and Africa through the Global Antibiotic Resistance Partnership. Through his prolific research,
active public outreach (including a TED talk that has been viewed over a million times) and sustained policy engagement,
he has played a central role in bringing the issue of drug resistance to the attention of leaders and policymakers
worldwide and to the United Nations General Assembly in September 2016.
During the Obama Administration, Laxminarayan served on the U.S. President’s Council of Advisors on Science and
Technology’s antimicrobial resistance working for group and was appointed a voting member of the U.S. Presidential
Advisory Council on Combating Antimicrobial Resistance.